Home » Topics » Regulatory » Patents

Patents
RSS

Chinese researchers divulge GTPase KRAS mutant inhibitors

Nov. 17, 2021

Assembly Biosciences patents new compounds for HBV

Nov. 17, 2021

C4X Discovery Holdings patents NFE2L2 activators

Nov. 16, 2021

Plexxikon identifies new CD73 inhibitors

Nov. 16, 2021

Taiho Pharmaceutical presents new GTPase KRAS mutant inhibitors

Nov. 16, 2021

Roche discloses GABA-A receptor PAMs

Nov. 16, 2021

Sumitomo Dainippon Pharma patents new compounds for epilepsy

Nov. 16, 2021

Assembly Biosciences synthesizes new HBV antivirals

Nov. 15, 2021

Janssen Pharmaceutica identifies NLRP3 inflammasome inhibitors

Nov. 15, 2021

Tenova Pharmaceuticals discloses EGFR and/or ALK inhibitors

Nov. 15, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...